Ginkgo Bioworks Holdings, Inc. (DNA) Latest Stock News
WEBGet the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock news and headlines to help you in your trading and investing decisions.
Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today
WEB2 days ago · The company is forging ahead with next-generation drug development solutions. Bioengineering specialist Ginkgo Bioworks Holdings (DNA 0.37%) delivered some badly needed good news for investors on ...
Ginkgo Bioworks Holdings, Inc. (DNA) - Yahoo Finance
WEBFind the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Ginkgo Bioworks makes a bet on AI, hoping for a turnaround - STAT
WEB9 hours ago · Amid layoffs and a disintegrating share price, former investor darling Ginkgo Bioworks is trying out a new tack to find customers. The biotech this week announced a new artificial intelligence ...
Ginkgo Bioworks Completes Program with Biogen to Boost …
WEBJan 4, 2024 · Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the successful completion of the gene therapy collaboration they...
Ginkgo Bioworks Announces Acquisition of AgBiome’s Platform …
WEBApr 11, 2024 · We’re thrilled to announce the acquisition of AgBiome’s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as …
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023 …
WEBFeb 29, 2024 · Ginkgo continues to expand its global bioradar network—with pilots, programs, or MOUs in 14 countries and 10 airports—and advance capabilities for multi-target and multimodal biological threat...
Ginkgo Bioworks Launches New Protein LLM and Model API Built …
WEB2 days ago · Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology. BOSTON, Sept. 17, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), which is building the ...
Acquiring Modulus Therapeutics’ Cell Therapy Assets - Ginkgo …
WEBApr 2, 2024 · Modulus’ assets complement Ginkgo’s extensive cell therapy capabilities. With this addition, Ginkgo looks forward to supporting its customers who are improving the performance of T-cell and NK-cell based CAR therapies to treat solid tumors, autoimmune, and other diseases.
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI …
WEB2 days ago · BOSTON, Sept. 18, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, proudly announces the launch of Ginkgo ...
Skip to content